Drug
Ly3537031
Ly3537031: highest development phase Phase 2, developed by Eli Lilly. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Eli Lilly
Trials
| Drug | Phase | Indication |
|---|---|---|
| LY3537031 NCT07545772 | Phase 2 | Irritable Bowel Syndrome |
| LY3537031 NCT04648865 | Phase 1 | Healthy |
Latest
No recent events.
Follow Ly3537031 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.